[Indications for beta-receptor blockaders in psychiatry].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D008881:Migraine Disorders / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000009:adverse effects; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D011619:Psychotropic Drugs
Indikationen für Beta-Rezeptorenblocker in der Psychiatrie.